Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.68 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.68 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.68 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | PTPRC | P08575 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.46 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.46 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28164029 | 0.93 | CYP2A6 (0.82) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL3997707 | 0.89 | — | — | |
| SCHEMBL5713686 | 0.87 | CYP2A6 (0.54) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL879221 | 0.84 | CYP2A6 (0.56) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL9194627 | 0.84 | CYP2A6 (0.56) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL2481528 | 0.84 | KCNH2 (0.57) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL30469250 | 0.84 | KCNH2 (0.57) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL2465613 | 0.84 | CYP2A6 (0.56) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL4442916 | 0.84 | HSD17B1 (0.58) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 | |
| SCHEMBL30172705 | 0.84 | CYP2A6 (0.56) | CYP2A6CYP2B6CYP2E1PRMT6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621045-A | Method for synthesizing polyaromatic hydrocarbon from aryl formaldehyde | 长沙资材科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| US-8889839-B2 | Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence | SYRACUSE UNIVERSITY (US) | 2014-11-18 | — | — | US | disclosed |
| US-20090281290-A1 | Pyridine-bis (oxazoline)(\"pybox\") moiety as a chelator and sensitizer for lanthanide Ion (Ln (III)) luminescence | SYRACUSE UNIVERSITY (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281290-A1 | Pyridine-bis (oxazoline)(\"pybox\") moiety as a chelator and sensitizer for lanthanide Ion (Ln (III)) luminescence | PYCR1, SSB, PNPO | CYP2A6 4842/4885CYP2B6 4672/4885CYP2E1 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.